Literature DB >> 2154887

Transcription of the human cytomegalovirus glycoprotein gene family in the short unique component of the viral genome.

D R Gretch1, M F Stinski.   

Abstract

The HXLF (HindIII X left reading frame) genes are a group of six open reading frames (ORFs) within the short unique component of the human cytomegalovirus genome. Two or more ORFs of the HXLF gene family code for components of the virion envelope glycoprotein complex designated gcII. Transcription of the various HXLF genes in infected cells was analyzed using specific DNA, RNA, and synthetic oligonucleotide probes. Transcription from each of the six HXLF genes was analyzed at immediate early, early, and late times after infection. Even though an enhancer element in six copies is downstream of HXLF6, immediate early cytoplasmic RNAs from the HXLF genes was not detectable. In contrast, early and late cytoplasmic RNAs were detectable for all six HXLF genes. The HXLF1 and 2 genes and the HXLF3 and 4 genes are transcribed as bicistronic mRNAs of 1.6 and 1.7 kb, respectively. The HXLF5 and 6 genes are transcribed as monocistronic mRNAs. In the HXLF4, 5, and 6 transcription units cytoplasmic viral RNAs were detected from both strands. Bidirectional transcription upstream of the enhancer element occurs at only early and late times after infection. The significance of bicistronic mRNA to the formation of the glycoprotein complex gcII requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154887     DOI: 10.1016/0042-6822(90)90106-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Expression of a human cytomegalovirus glycoprotein multigene family.

Authors:  D R Gretch; J F Bale; R C Gehrz; M F Stinski
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

2.  A 15-kilobase-pair region of the human cytomegalovirus genome which includes US1 through US13 is dispensable for growth in cell culture.

Authors:  A Kollert-Jöns; E Bogner; K Radsak
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

Review 3.  Molecular biology of cytomegalovirus.

Authors:  V C Emery; P D Griffiths
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

4.  Mutation of glutamine to arginine at position 548 of IE2 86 in human cytomegalovirus leads to decreased expression of IE2 40, IE2 60, UL83, and UL84 and increased transcription of US8-9 and US29-32.

Authors:  Sarah W Burgdorf; Charles L Clark; James R Burgdorf; Deborah H Spector
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

5.  Structural analysis of the US-segment of a viable temperature sensitive human cytomegalovirus mutant.

Authors:  T Mockenhaupt; M Reschke; E Bogner; B Reis; K Radsak
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Alternate promoter selection within a human cytomegalovirus immediate-early and early transcription unit (UL119-115) defines true late transcripts containing open reading frames for putative viral glycoproteins.

Authors:  M P Leatham; P R Witte; M F Stinski
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Fine mapping of transcripts expressed from the US6 gene family of human cytomegalovirus strain AD169.

Authors:  T R Jones; V P Muzithras
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

8.  Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.

Authors:  K Ahn; A Angulo; P Ghazal; P A Peterson; Y Yang; K Früh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains.

Authors:  T R Jones; L K Hanson; L Sun; J S Slater; R M Stenberg; A E Campbell
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope.

Authors:  B Kari; R Gehrz
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.